Drug intelligence / Profile preview

cefatrizine

Development stage
Unknown
Lead developer
Yungjin Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Cefatrizine is a broad-spectrum, semisynthetic, first-generation cephalosporin antibiotic. It acts by binding to and inactivating penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and reshaping it during growth and division. Inactivation of these proteins interferes with cross-linking of peptidoglycan chains, weakening the bacterial cell wall and leading to cell lysis. Cefatrizine is used primarily for treating a variety of bacterial infections including those affecting the respiratory tract, ear, skin, and urinary tract[2][3][7]. It is less effective against some gram-positive bacteria compared to other first-generation cephalosporins[7].

Brand names
CefatrixCepticolCetrazilLatocefOrosporinaTrizinaBricef
Other names
cefatrizinecefatrizinumcefatrizinacefatrizinocephatriazineantibiotic BL-S 640UNII:8P4W949T8KJ01DB07J-01DB07J 01DB07
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cefatrizine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefatrizine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call